EA200800200A1 - Способ получения кристаллического периндоприла - Google Patents

Способ получения кристаллического периндоприла

Info

Publication number
EA200800200A1
EA200800200A1 EA200800200A EA200800200A EA200800200A1 EA 200800200 A1 EA200800200 A1 EA 200800200A1 EA 200800200 A EA200800200 A EA 200800200A EA 200800200 A EA200800200 A EA 200800200A EA 200800200 A1 EA200800200 A1 EA 200800200A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining crystalline
perindopril
crystalline perindopril
preparation
relates
Prior art date
Application number
EA200800200A
Other languages
English (en)
Other versions
EA013018B1 (ru
Inventor
Бранко Энко
Антон Копар
Original Assignee
Лек Фармасьютиклз Д. Д.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лек Фармасьютиклз Д. Д. filed Critical Лек Фармасьютиклз Д. Д.
Publication of EA200800200A1 publication Critical patent/EA200800200A1/ru
Publication of EA013018B1 publication Critical patent/EA013018B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к новому способу получения кристаллического периндоприла. Настоящее изобретение также относится к новым солям алкиламмония и периндоприла и способам их получения.
EA200800200A 2005-07-25 2006-07-24 Способ получения кристаллического периндоприла EA013018B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200500214 2005-07-25
PCT/EP2006/007258 WO2007017087A1 (en) 2005-07-25 2006-07-24 Process for the preparation of crystalline perindopril

Publications (2)

Publication Number Publication Date
EA200800200A1 true EA200800200A1 (ru) 2008-06-30
EA013018B1 EA013018B1 (ru) 2010-02-26

Family

ID=37451139

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800200A EA013018B1 (ru) 2005-07-25 2006-07-24 Способ получения кристаллического периндоприла

Country Status (14)

Country Link
US (1) US7923570B2 (ru)
EP (1) EP1910287B1 (ru)
JP (1) JP4972643B2 (ru)
CN (1) CN101228126B (ru)
AT (1) ATE549315T1 (ru)
AU (1) AU2006278866B2 (ru)
BR (1) BRPI0613976A2 (ru)
CA (1) CA2615691C (ru)
EA (1) EA013018B1 (ru)
MX (1) MX2008001151A (ru)
SI (1) SI1910287T1 (ru)
UA (1) UA92752C2 (ru)
WO (1) WO2007017087A1 (ru)
ZA (1) ZA200800138B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090099370A1 (en) * 2005-08-12 2009-04-16 Sandoz Ag Crystalline Form of Perindopril Erbumine
UA92613C2 (ru) * 2005-08-12 2010-11-25 Лек Фармасьютиклз Д.Д. Способ получения кристаллической формы d эрбумина периндоприла
SI22543A (sl) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
GB0910692D0 (en) * 2009-06-20 2009-08-05 Teva Pharma Compound
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
WO2005019173A1 (en) * 2003-08-21 2005-03-03 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia

Also Published As

Publication number Publication date
CN101228126B (zh) 2011-10-19
CA2615691A1 (en) 2007-02-15
AU2006278866A1 (en) 2007-02-15
MX2008001151A (es) 2008-03-13
US7923570B2 (en) 2011-04-12
SI1910287T1 (sl) 2012-09-28
US20080306135A1 (en) 2008-12-11
AU2006278866B2 (en) 2012-03-15
JP2009502833A (ja) 2009-01-29
ZA200800138B (en) 2009-08-26
JP4972643B2 (ja) 2012-07-11
BRPI0613976A2 (pt) 2011-02-22
EA013018B1 (ru) 2010-02-26
CA2615691C (en) 2015-11-10
UA92752C2 (ru) 2010-12-10
CN101228126A (zh) 2008-07-23
EP1910287B1 (en) 2012-03-14
ATE549315T1 (de) 2012-03-15
EP1910287A1 (en) 2008-04-16
WO2007017087A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
EA200702586A1 (ru) Кристаллические модификации пираклостробина
EA200800549A1 (ru) Региоселективный способ получения бензимидазолтиофенов
EA200900793A1 (ru) Способ получения эзетимиба и его производных
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
UA96961C2 (ru) Азаадамантановые производные и способы применения
UY33981A (es) ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?.
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
MA32255B1 (fr) Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
EA201071120A1 (ru) Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида
CY1109838T1 (el) Μεθοδος δια παρασκευη 3-ο-προστατευμενων μορφινονων και καρβοξυλικων αλατων διενολης 3-ο-προστατευμενης μορφινονης
NO20064884L (no) Kjemisk fremgangsmate og ny krystallinsk form
TW200635905A (en) Processes for producing 4-aminoquinazolines
TW200612959A (en) Method for preparing hydroxamic acids
EA200800200A1 (ru) Способ получения кристаллического периндоприла
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200701852A1 (ru) Производные аминокислот
EA200801573A1 (ru) Способ получения кристаллических форм орлистата
ATE465152T1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
ATE529413T1 (de) Verfahren zur synthese von aryloxydiaminopyrimidinen
NO20074259L (no) Fremgangsmate for fremstilling av substituerte benzoksazolforbindelser
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
EA200800466A1 (ru) Способ получения эрбумина периндоприла

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ RU